Status:
UNKNOWN
The University of Hong Kong Neurocognitive Disorder Cohort
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Dementias Platform UK
Conditions:
Neurocognitive Disorder
Mild Cognitive Impairment
Eligibility:
All Genders
65+ years
Brief Summary
The HKU Neurocognitive Disorder (NCD) Cohort is a hospital-based, prospective, observational study of older HK Chinese adults with cognitive impairment, with a special focus on studying patients with ...
Detailed Description
The HKU Neurocognitive Disorder (NCD) Cohort is a hospital-based, prospective, observational study of older HK Chinese adults with cognitive impairment, with a special focus on studying patients with ...
Eligibility Criteria
Inclusion
- Older adults with or without neurocognitive disoder. HKU NCD Cohort focuses primarily on people with Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI).
Exclusion
- Severe Parkinson's disease, major depressive disorder or severe psychiatric conditions, significant communication difficulties (e.g. aphasia, deafness), terminal cancer or likely end-of-life in the next 12 months.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 4 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03275363
Start Date
September 1 2014
End Date
January 4 2022
Last Update
September 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Queen Mary Hospital, The University of Hong Kong
Hong Kong, Hong Kong